STOCK TITAN

Quest Diagnostics Names Adrienne Brott Senior Vice President and Chief Quality and Regulatory Affairs Officer

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Very Positive)
Tags

Quest Diagnostics (NYSE: DGX) has appointed Adrienne L. Brott as senior vice president and chief quality and regulatory affairs officer, effective December 2024. Reporting to CEO Jim Davis, Brott will lead the company's quality and regulatory strategy, focusing on enhancing quality adherence and compliance with global regulations for laboratory diagnostic services.

Brott joins Quest with extensive experience in healthcare quality and regulatory affairs, previously serving as senior vice president of quality and regulatory at Getinge's acute care therapies division. Her prior roles include leadership positions at Becton Dickinson, where she managed quality across 28 manufacturing sites and led a program to harmonize 120 quality management systems. She also held positions at Johnson & Johnson and Abbott Laboratories.

The new executive is co-chair of the Advancing Quality Excellence Collaborative Community Steering Committee of the Medical Device Innovation Consortium, collaborating with stakeholders including the FDA to improve medical device quality and patient safety.

Loading...
Loading translation...

Positive

  • Strategic appointment strengthens regulatory compliance capabilities
  • New executive brings extensive experience from major healthcare companies
  • Addition of seasoned leader to executive team enhances quality management expertise

Negative

  • None.

News Market Reaction – DGX

+0.25%
1 alert
+0.25% News Effect

On the day this news was published, DGX gained 0.25%, reflecting a mild positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

Quality and regulatory veteran of Getinge, BD and J&J joins the Quest Diagnostics executive team

SECAUCUS, N.J., Jan. 8, 2025 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), a leading provider of diagnostic information services, today announced that Adrienne L. Brott, an accomplished quality and regulatory affairs healthcare leader, has been named senior vice president and chief quality and regulatory affairs officer.

Ms. Brott is responsible for leading the company's quality and regulatory strategy to enhance quality adherence and control as well as compliance with U.S. and global regulations and industry standards for laboratory diagnostic information services. She reports to Jim Davis, Chairman, CEO and President, and is a member of the company's Executive Leadership Team. Ms. Brott is based at the company's headquarters in Secaucus, NJ. Her appointment took effect in December 2024.

"Adrienne is a highly effective leader with an impressive record of strengthening and streamlining quality and regulatory processes for complex healthcare companies," Mr. Davis said. "Under her leadership, Quest will be well positioned to navigate an evolving regulatory landscape and fulfill our high standards for quality."

Prior to joining Quest, Ms. Brott was senior vice president, quality and regulatory for the acute care therapies division of Getinge, a global medical technology company. Before that, she held various leadership roles at Becton Dickinson (BD), a leading global medical technology company. This includes senior vice president, quality management--interventional segment, quality systems and regions, where she led all aspects of quality across 28 manufacturing sites worldwide and led a multi-year program to simplify and harmonize 120 quality management systems. She held other roles of increasing responsibility in quality systems and post-market quality and regulatory compliance and quality operations and end-to-end integrated supply chain operations for medical devices and other areas for Johnson & Johnson and Abbott Laboratories.

Ms. Brott is a co-chair of the Advancing Quality Excellence Collaborative Community (AQEcc) Steering Committee of the Medical Device Innovation Consortium (MDIC), an initiative shared by medical device stakeholders, including the FDA, to enhance medical device quality and patient safety.

Ms. Brott earned a Master of Business Administration (M.B.A.) degree from the Lake Forest Graduate School of Management and a bachelor's degree with a double major in biology and environmental studies from Lake Forest College in Illinois.

About Quest Diagnostics
Quest Diagnostics works across the healthcare ecosystem to create a healthier world, one life at a time. We provide diagnostic insights from the results of our laboratory testing to empower people, physicians and organizations to take action to improve health outcomes. Derived from one of the world's largest databases of de-identifiable clinical lab results, Quest's diagnostic insights reveal new avenues to identify and treat disease, inspire healthy behaviors and improve healthcare management. Quest Diagnostics annually serves one in three adult Americans and half the physicians and hospitals in the United States, and our more than 50,000 employees understand that, in the right hands and with the right context, our diagnostic insights can inspire actions that transform lives and create a healthier world. www.QuestDiagnostics.com.

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/quest-diagnostics-names-adrienne-brott-senior-vice-president-and-chief-quality-and-regulatory-affairs-officer-302345585.html

SOURCE Quest Diagnostics

FAQ

When did Adrienne Brott join Quest Diagnostics (DGX) as chief quality officer?

Adrienne Brott joined Quest Diagnostics as senior vice president and chief quality and regulatory affairs officer in December 2024.

What is Adrienne Brott's role at Quest Diagnostics (DGX)?

Brott leads Quest's quality and regulatory strategy, focusing on enhancing quality adherence and compliance with U.S. and global regulations for laboratory diagnostic services.

What was Adrienne Brott's previous position before joining Quest Diagnostics (DGX)?

Before joining Quest, Brott was senior vice president of quality and regulatory for the acute care therapies division at Getinge, a global medical technology company.

What are Adrienne Brott's key achievements at Becton Dickinson before joining DGX?

At Becton Dickinson, Brott led quality management across 28 manufacturing sites worldwide and managed a multi-year program to simplify and harmonize 120 quality management systems.
Quest Diagnostics Inc

NYSE:DGX

DGX Rankings

DGX Latest News

DGX Latest SEC Filings

DGX Stock Data

22.90B
109.04M
Diagnostics & Research
Services-medical Laboratories
Link
United States
SECAUCUS